Melatonin, widely recognized as a sleep hormone, can lower nighttime blood pressure by a clinically meaningful amount, but only in certain formulations and circumstances. A meta-analysis of randomized controlled trials found that controlled-release melatonin reduced nocturnal systolic blood pressure by about 6 mmHg, while standard fast-release melatonin had virtually no effect. The story gets more complicated from there. In some patients, melatonin actually raised blood pressure, and interactions with common blood pressure medications range from helpful to potentially dangerous.
Why Nighttime Blood Pressure Matters
Blood pressure normally dips by 10 to 20 percent during sleep. People whose pressure fails to drop at night are called “nondippers,” and they face higher risks of heart attack, stroke, and kidney damage than people whose pressure follows the expected nighttime decline. Nocturnal hypertension is common in older adults, people with diabetes, and those with chronic kidney disease. Melatonin’s role here makes intuitive sense: the hormone is released by the pineal gland in darkness, and its natural surge coincides with the time window when blood pressure should be falling. When that surge is blunted, whether by aging, shift work, or medication, the nighttime dip can disappear.
A trial specifically enrolling patients with nocturnal hypertension found that controlled-release melatonin taken before bed reduced nighttime systolic pressure from about 136 to 130 mmHg, with the strongest effect between 2:00 and 5:00 AM. Placebo had no effect.1PubMed. Melatonin reduces night blood pressure in patients with nocturnal hypertension That 6-point drop is in the range of what mild blood pressure drugs achieve, which is why researchers have paid attention despite melatonin’s reputation as a benign supplement.
Controlled-Release Versus Fast-Release
The distinction between controlled-release and fast-release melatonin turns out to be the single most important variable in whether melatonin lowers blood pressure. A meta-analysis pooling data from multiple randomized trials found that controlled-release melatonin lowered nocturnal systolic pressure by about 6 mmHg and diastolic pressure by roughly 3.5 mmHg. Fast-release melatonin, by contrast, reduced systolic pressure by less than half a point, a result indistinguishable from placebo.2PubMed Central. Effect of melatonin on nocturnal blood pressure: meta-analysis of randomized controlled trials – Section: Results A separate systematic review confirmed this pattern, finding that only controlled-release melatonin reduced sleeping systolic pressure.3PubMed Central. Controlled-release oral melatonin supplementation for hypertension and nocturnal hypertension: A systematic review and meta-analysis
This makes physiological sense. The body’s natural melatonin release is not a spike; it builds gradually after dark and stays elevated for hours. A fast-release pill floods the system with melatonin that clears within an hour or two, mimicking something the body does not normally do. A controlled-release tablet delivers melatonin over several hours, more closely matching the natural secretion curve and keeping levels elevated during the critical window when blood pressure is supposed to be at its lowest. If you are interested in melatonin specifically for blood pressure rather than just sleep onset, formulation is not a minor detail.
How Melatonin Affects Blood Vessels
The blood pressure effect is not simply a matter of relaxation or better sleep, though both help. Melatonin acts on blood vessels through several independent pathways. It scavenges free radicals and activates the body’s own antioxidant enzymes, which protects the endothelium, the thin lining of blood vessels that controls how much they dilate or constrict. Melatonin also increases the availability of nitric oxide, the molecule that signals blood vessels to relax.4Europe PMC. Vascular endothelial cells and dysfunctions: role of melatonin In animal models of hypertension, melatonin improved vascular function by reducing the infiltration of inflammatory cells into artery walls and restoring nitric oxide production.
A 2025 study added another piece to this picture, showing that melatonin restores the function of perivascular adipose tissue, the fat that surrounds arteries and normally helps them relax. In hypertension, this tissue becomes dysfunctional and actually promotes constriction. Melatonin reversed that dysfunction by reducing oxidative stress, preserving antioxidant enzyme activity, and improving nitric oxide levels in the tissue.5PubMed. Melatonin protects vascular homeostasis by restoring PVAT redox balance in arterial hypertension
There is also a nervous system component. Melatonin appears to dial down the sympathetic nervous system, the “fight or flight” branch that raises heart rate and constricts blood vessels. Research in hypertensive animals found that melatonin’s blood pressure-lowering effect was linked to reduced sympathetic tone and a partial blockade of the receptors that adrenaline uses to tighten blood vessels.6American Journal of Hypertension. Impaired Basal Sympathetic Tone and α1-Adrenergic Responsiveness in Association With the Hypotensive Effect of Melatonin in Spontaneously Hypertensive Rats One pathway that melatonin does not seem to work through is the renin-angiotensin-aldosterone system, the hormonal cascade that many common blood pressure drugs target. In an experimental hypertension model, melatonin protected the heart and kidneys without changing angiotensin or aldosterone levels.7PubMed Central. Effect of Melatonin on the Renin-Angiotensin-Aldosterone System in l-NAME-Induced Hypertension – Section: 2.3. The Serum Concentrations of Angiotensins and Aldosterone That distinction matters for thinking about how melatonin might fit alongside, rather than duplicate, existing medications.
People With Metabolic Disorders See Larger Benefits
Melatonin’s blood pressure effects are not uniform across all populations. A meta-analysis of randomized controlled trials focused specifically on people with metabolic disorders, including type 2 diabetes and metabolic syndrome, and found significant reductions in both systolic and diastolic blood pressure with melatonin supplementation.8Journal of Human Hypertension. The effects of melatonin supplementation on blood pressure in patients with metabolic disorders: a systematic review and meta-analysis of randomized controlled trials This tracks with what we know about these conditions: metabolic disorders are associated with increased oxidative stress, chronic low-grade inflammation, and disrupted circadian rhythms, all of which melatonin directly counteracts. People with well-controlled blood pressure and no metabolic issues are less likely to see dramatic changes.
Cardiovascular disease more broadly also appears to be a context where melatonin shows promise. A 2022 review of the evidence concluded that melatonin has shown significant benefits in reducing cardiac damage and protecting heart muscle, though the authors noted that its ability to lower primary hypertension still needs more extensive evaluation in large human trials.9PubMed Central. Evidence for the Benefits of Melatonin in Cardiovascular Disease The research is encouraging but has mostly been conducted in small studies. The cardiovascular community has not yet produced the kind of large, long-term trials that would change treatment guidelines.
The Daytime Trade-Off
One of the genuinely surprising findings in this literature is that melatonin does not simply lower blood pressure across the board. In a 90-day study of coronary artery disease patients who were nondippers, evening melatonin did lower nighttime systolic pressure. But it also raised daytime systolic and diastolic pressure. The net effect was that the day-night blood pressure ratio shifted, making the 24-hour pattern look more normal, but at the cost of higher waking readings.10Hypertension Research. Melatonin for nondippers with coronary artery disease: assessment of blood pressure profile and heart rate variability – Section: Results The researchers concluded that melatonin should not be recommended for patients with “high normal” daytime blood pressure because it could push them into hypertensive territory during waking hours.
This is a genuinely underappreciated risk. Most people who look into melatonin for blood pressure are focused on bringing numbers down, not on the possibility of numbers going up during the day. The effect makes sense once you think about circadian biology: melatonin is essentially resetting the body’s pressure rhythm, amplifying the difference between daytime highs and nighttime lows. For a true nondipper, that is exactly the pattern you want to restore. For someone whose daytime pressure is already borderline, amplifying it could be counterproductive.
A Dangerous Interaction With Calcium Channel Blockers
Perhaps the most alarming finding in the melatonin-blood pressure literature involves nifedipine, a widely prescribed calcium channel blocker. In a 24-hour study of hypertensive patients whose blood pressure was well controlled on nifedipine, a single evening dose of melatonin increased systolic blood pressure by about 6.5 mmHg and diastolic pressure by roughly 5 mmHg over the full day. Heart rate also rose. The researchers hypothesized that melatonin competes with nifedipine at calcium channels, effectively undermining the drug’s ability to relax blood vessels.11PubMed Central. Cardiovascular effects of melatonin in hypertensive patients well controlled by nifedipine: a 24-hour study – Section: Results
A 6.5 mmHg rise in systolic pressure is not trivial, especially in someone whose blood pressure was stable on medication. If a patient on nifedipine starts taking melatonin for sleep without mentioning it to their doctor, they could be unknowingly erasing much of their medication’s benefit. This is the kind of supplement-drug interaction that rarely makes the news but has real clinical consequences. Nifedipine is one of the most commonly used blood pressure medications globally, and melatonin is available without a prescription in most countries.
Whether this interaction extends to other calcium channel blockers like amlodipine or diltiazem is not well established. The mechanism the researchers proposed, competition at calcium channels, would theoretically apply to the class, but direct studies on other agents are sparse. Until more data exist, caution with any calcium channel blocker seems reasonable.
The Beta-Blocker Connection
The relationship between melatonin and beta-blockers runs in the opposite direction and is surprisingly well documented. Beta-blockers, one of the most widely prescribed classes of blood pressure medication, suppress the body’s nighttime melatonin production by blocking the specific receptors on the pineal gland that trigger melatonin release.12PubMed Central. Night-time exogenous melatonin administration may be a beneficial treatment for sleeping disorders in beta blocker patients This is why insomnia is such a common side effect of beta-blockers, and it creates a vicious cycle: poor sleep itself raises blood pressure, potentially working against the very drug that caused the sleep problem.
A randomized controlled trial tested whether melatonin supplements could break this cycle. Hypertensive patients on beta-blockers who took melatonin before bed experienced improved sleep.13PubMed Central. Repeated Melatonin Supplementation Improves Sleep in Hypertensive Patients Treated with Beta-Blockers: A Randomized Controlled Trial Unlike the nifedipine interaction, melatonin does not appear to compete with beta-blockers at their receptor targets. The two actually work on different systems: beta-blockers lower blood pressure mainly by reducing heart rate and cardiac output, while melatonin acts on blood vessels and the sympathetic nervous system through separate mechanisms. This makes the combination potentially complementary rather than antagonistic, though anyone on beta-blockers should still discuss melatonin with their prescriber.
Shift Work, Melatonin Suppression, and Hypertension Risk
The connection between disrupted melatonin rhythms and high blood pressure extends well beyond supplements. Shift workers, whose exposure to light at night chronically suppresses natural melatonin production, have measurably higher rates of hypertension. A cross-sectional study found that after adjusting for other risk factors, shift workers had roughly 50 percent higher odds of developing hypertension compared to day workers. The risk was especially pronounced in those who had been doing shift work for over 20 years.14PubMed Central. Effect of shift work on hypertension: cross sectional study – Section: RESULTS
This association does not prove that melatonin suppression alone is responsible, since shift work disrupts diet, exercise, stress, and social rhythms as well. But it fits a larger pattern: conditions that suppress natural melatonin, whether shift work, aging, beta-blocker use, or excessive evening light exposure, tend to correlate with higher blood pressure and loss of the normal nighttime dip. Whether melatonin supplementation could specifically protect shift workers from hypertension has not been tested in large trials, but the biological rationale is there.
Kidney Disease and Melatonin
Chronic kidney disease creates a particularly challenging blood pressure situation. The kidneys play a central role in long-term blood pressure regulation, and as kidney function declines, hypertension becomes both more common and harder to treat. Nocturnal hypertension is especially prevalent in this population. Melatonin’s potential here comes from several angles: its antioxidant and anti-inflammatory properties could protect remaining kidney tissue, while its blood pressure effects could help restore the nighttime dip that kidney patients so frequently lose.
A review of melatonin’s role in kidney diseases found that its antioxidant and protective properties are relevant to virtually every type of kidney injury, since oxidative stress, inflammation, and cell death are common to all of them. The authors concluded that melatonin supplementation has a renoprotective effect and can slow the progression of complications associated with kidney failure.15PubMed Central. Melatonin Treatment in Kidney Diseases This is still an area where clinical evidence in humans is limited compared to the animal data, but it represents one of the more promising overlaps between melatonin’s vascular effects and a specific disease population that desperately needs better options for nocturnal blood pressure control.
Practical Considerations for Anyone Thinking About Melatonin and Blood Pressure
The evidence supports a few concrete takeaways for people considering melatonin with blood pressure in mind. Controlled-release formulations are the only ones that have shown consistent blood pressure benefits; if you are buying melatonin off the shelf and it dissolves quickly under your tongue or claims “fast-acting,” it is unlikely to do much for your pressure. Doses used in the blood pressure studies were typically in the range of 2 to 3 mg taken in the evening, which is on the lower end of what many supplement brands sell. Higher doses have not been shown to produce larger blood pressure effects.
Timing matters. The trials showing blood pressure benefits gave melatonin in the evening, roughly two hours before bed, aligning the supplemental dose with the window when natural melatonin secretion would normally begin. Taking melatonin at odd hours, as some shift workers do to force sleep, might not reproduce the blood pressure effects seen in trials.
The drug interaction picture is the most important practical consideration. If you take a calcium channel blocker like nifedipine, melatonin could raise your blood pressure rather than lower it. If you take a beta-blocker, melatonin may improve your sleep without undermining your medication. These are opposite outcomes from the same supplement, determined entirely by what else you are taking. This is a strong argument for mentioning melatonin use to a doctor, something many people skip because they think of it as “just a supplement.”
The daytime blood pressure increase seen in some studies also deserves attention. If your blood pressure runs high during the day and you add melatonin hoping to bring it down, you could end up worse off during waking hours. Home blood pressure monitoring, ideally with readings at different times of day, is the only way to know whether melatonin is helping your overall profile or just reshuffling when your pressure peaks.
How Melatonin Fits Into the Bigger Cardiovascular Toolkit
Melatonin is not going to replace blood pressure medication for anyone with established hypertension. The reductions seen in trials, while meaningful, are modest compared to standard drugs, and the evidence base is still relatively small. Where melatonin seems to have its niche is in addressing the specific problem of nocturnal hypertension and the absent nighttime dip, issues that standard medications sometimes struggle with. Adding controlled-release melatonin to an existing regimen could, in theory, provide a nighttime benefit that daytime-focused drugs miss, but only if the specific drug interaction profile is safe.
The field also still lacks clarity on long-term outcomes. We know melatonin lowers nighttime blood pressure in short-term trials, but whether that translates to fewer heart attacks or strokes over years has not been demonstrated. Blood pressure is a surrogate endpoint, a number that predicts risk but is not itself the disease. Lowering it with melatonin should reduce risk based on everything we know about blood pressure physiology, but the direct evidence is not there yet. For now, melatonin occupies an interesting space: a supplement with real, measurable vascular effects that happen to depend enormously on details most users never think about, like whether their pill dissolves in 20 minutes or over several hours.